Cargando…
Delayed spontaneous resolution of nephrotic syndrome in a patient with hepatitis C virus-associated membranoproliferative glomerulonephritis
Treatment with antiviral and/or immunosuppressive therapy is considered the standard care in patients with hepatitis C virus (HCV)-associated membranoproliferative glomerulonephritis (MPGN). However, even with an adequate therapy, a favourable response is not always guaranteed. In patients with HCV-...
Autores principales: | Sandhu, Gagangeet, Stokes, M. Barry, Meisels, Ira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421529/ https://www.ncbi.nlm.nih.gov/pubmed/25949432 http://dx.doi.org/10.1093/ndtplus/sfq078 |
Ejemplares similares
-
Membranoproliferative glomerulonephritis
por: Alchi, Bassam, et al.
Publicado: (2009) -
Rituximab therapy for hepatitis C virus‐associated cryoglobulinemic membranoproliferative glomerulonephritis
por: Koratala, Abhilash, et al.
Publicado: (2018) -
Altered mental status in a case of multiple myeloma not related to a metabolic cause
por: Sandhu, Gagangeet, et al.
Publicado: (2009) -
Portal Vein Thrombosis in a 21-Year-Old Man with Membranoproliferative Glomerulonephritis and Nephrotic Syndrome
por: Seleznev, Ilya, et al.
Publicado: (2019) -
Hepatitis C Virus-associated Membranoproliferative Glomerulonephritis Treated with Directly Acting Antiviral Therapy
por: Nayak, S., et al.
Publicado: (2018)